1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Condition
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing prevalence of neurological diseases
4.1.1.2. Technological advancements
4.1.2. Restraints
4.1.2.1. High cost of diagnosis and procedure
4.1.3. Opportunity
4.1.3.1. The development of portable, wearable and mobile neurodiagnostic devices
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Force Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Impact Analysis
9. By Product
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.1.2. Market Attractiveness Index, By Product
9.2. Diagnostic & Imaging Systems
9.2.1. Computed Tomography (CT) Scanner
9.2.2. Electroencephalogram (EEG) Systems
9.2.3. Position emission tomography (PET) System
9.2.4. Electromyography (EMG) Products
9.2.5. Ultrasound Imaging Systems
9.2.6. Magnetoencephalogram (MEG) System
9.2.7. Angiography System
9.2.8. Other Systems
9.2.9. Introduction
9.2.10. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinical Testing Instruments
9.3.1. Polymerase Chain Reaction (PCR)
9.3.2. Next Generation Sequencing (NGS)
9.3.3. Sanger Sequencing
9.3.4. Other Clinical Diagnostic Products
9.4. Reagents & Consumables
9.4.1. Enzymes, Protein & Peptides
9.4.2. Buffers
9.4.3. Probes
9.4.4. Media and Serra
9.4.5. Solvents
9.4.6. Antibodies
9.4.7. Other Reagents
10. By Condition
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Condition
10.1.2. Market Attractiveness Index, By Condition
10.2. Neuro Degenerative Disease
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Epilepsy
10.4. Stroke
10.5. Headache Disorder
10.6. Sleep Disorder
10.7. Others
11. By End-User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.1.2. Market Attractiveness Index, By End-User
11.2. Hospital and Surgery Centers
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Ambulatory Care Centers
11.4. Diagnostic Laboratories & Imaging Centers
11.5. Neurology Centers
11.6. Others
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Condition
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.6.1. The U.S.
12.2.6.2. Canada
12.2.6.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Condition
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.6.1. Germany
12.3.6.2. The U.K.
12.3.6.3. France
12.3.6.4. Italy
12.3.6.5. Spain
12.3.6.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Condition
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.6.1. Brazil
12.4.6.2. Argentina
12.4.6.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Condition
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.6.1. China
12.5.6.2. India
12.5.6.3. Japan
12.5.6.4. Australia
12.5.6.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Condition
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. Hoffman-La Roche AG
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. GE Healthcare
14.3. Siemens Healthineers
14.4. Philips Healthcare
14.5. Hitachi Ltd
14.6. FUJIFILM Holdings Corporation
14.7. Mitsar Co Ltd
14.8. Thermo Fischer Scientific Inc
14.9. Bio-Rad Laboratories
14.10. QIAGEN NV
15. Appendix
15.1. About Us and Services
15.2. Contact Us